SPDR S&P Biotech (NYSEARCA:XBI) Shares Bought by Appleton Group LLC

Appleton Group LLC raised its position in SPDR S&P Biotech (NYSEARCA:XBI) by 24.2% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 8,133 shares of the exchange traded fund’s stock after buying an additional 1,585 shares during the period. SPDR S&P Biotech makes up 0.7% of Appleton Group LLC’s holdings, making the stock its 18th largest position. Appleton Group LLC’s holdings in SPDR S&P Biotech were worth $628,000 as of its most recent SEC filing.

Other hedge funds have also bought and sold shares of the company. Crescent Grove Advisors LLC acquired a new stake in SPDR S&P Biotech during the second quarter worth about $6,794,000. National Planning Corp purchased a new stake in shares of SPDR S&P Biotech during the second quarter valued at about $211,000. HL Financial Services LLC increased its stake in shares of SPDR S&P Biotech by 10.3% in the second quarter. HL Financial Services LLC now owns 20,237 shares of the exchange traded fund’s stock valued at $1,562,000 after buying an additional 1,886 shares during the period. IFP Advisors Inc increased its stake in shares of SPDR S&P Biotech by 5.1% in the second quarter. IFP Advisors Inc now owns 10,213 shares of the exchange traded fund’s stock valued at $788,000 after buying an additional 496 shares during the period. Finally, Rand Wealth LLC increased its stake in shares of SPDR S&P Biotech by 1.8% in the second quarter. Rand Wealth LLC now owns 49,147 shares of the exchange traded fund’s stock valued at $3,793,000 after buying an additional 863 shares during the period.

Shares of SPDR S&P Biotech (NYSEARCA XBI) opened at 74.47 on Friday. SPDR S&P Biotech has a 12 month low of $53.15 and a 12 month high of $82.38. The firm has a 50-day moving average of $78.58 and a 200 day moving average of $71.46.

COPYRIGHT VIOLATION NOTICE: “SPDR S&P Biotech (NYSEARCA:XBI) Shares Bought by Appleton Group LLC” was first published by Community Financial News and is owned by of Community Financial News. If you are reading this piece of content on another publication, it was illegally copied and reposted in violation of U.S. and international copyright & trademark laws. The legal version of this piece of content can be accessed at https://www.com-unik.info/2017/08/11/spdr-sp-biotech-nysearcaxbi-shares-bought-by-appleton-group-llc.html.

About SPDR S&P Biotech

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

Institutional Ownership by Quarter for SPDR S&P Biotech (NYSEARCA:XBI)

What are top analysts saying about SPDR S&P Biotech? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for SPDR S&P Biotech and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit